Percutaneous extracorporeal life support: Reserve for patients with reversible causes of shock and cardiac arrest *
- 1 March 2003
- journal article
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 31 (3) , 978-980
- https://doi.org/10.1097/01.ccm.0000053517.17540.37
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Long-Term Use of a Left Ventricular Assist Device for End-Stage Heart FailureNew England Journal of Medicine, 2001
- The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2American Heart Journal, 2001
- Extracorporeal Life SupportJAMA, 2000
- Extracorporeal Life Support to Left Ventricular Assist Device Bridge to Heart Transplant : A Strategy to Optimize Survival and Resource UtilizationCirculation, 1999
- Extracorporeal Life Support for 100 Adult Patients With Severe Respiratory FailureAnnals of Surgery, 1997
- Use of Intraaortic Balloon Counterpulsation in Patients Presenting With Cardiogenic Shock: Observations From the GUSTO-I Study fn1fn1This study was funded by grants from Bayer, New York, New York; CIBA-Corning, Medfield, Massachusetts; Genentech, South San Francisco, California; ICI Pharmaceuticals, Wilmington, Delaware; and Sanofi Pharmaceuticals, Paris, France.Journal of the American College of Cardiology, 1997
- Prophylactic versus standby cardiopulmonary support for high risk percutaneous transluminal coronary angioplastyJournal of the American College of Cardiology, 1993
- Augmentation of coronary blood flow by intra-aortic balloon pumping in patients after coronary angioplasty.Circulation, 1993
- Treatment of cardiogenic shock with the hemopump left ventricular assist deviceThe Annals of Thoracic Surgery, 1991
- Extracorporeal Membrane Oxygenation in Severe Acute Respiratory FailureJAMA, 1979